282 related articles for article (PubMed ID: 35348002)
1. Platelet-Derived Growth Factor Receptor Type α Activation Drives Pulmonary Vascular Remodeling Via Progenitor Cell Proliferation and Induces Pulmonary Hypertension.
Solinc J; Raimbault-Machado J; Dierick F; El Bernoussi L; Tu L; Thuillet R; Mougenot N; Hoareau-Coudert B; Monceau V; Pavoine C; Atassi F; Sassoon D; Marazzi G; Harvey RP; Schofield P; Christ D; Humbert M; Guignabert C; Soubrier F; Nadaud S
J Am Heart Assoc; 2022 Apr; 11(7):e023021. PubMed ID: 35348002
[TBL] [Abstract][Full Text] [Related]
2. Resident PW1+ Progenitor Cells Participate in Vascular Remodeling During Pulmonary Arterial Hypertension.
Dierick F; Héry T; Hoareau-Coudert B; Mougenot N; Monceau V; Claude C; Crisan M; Besson V; Dorfmüller P; Marodon G; Fadel E; Humbert M; Yaniz-Galende E; Hulot JS; Marazzi G; Sassoon D; Soubrier F; Nadaud S
Circ Res; 2016 Mar; 118(5):822-33. PubMed ID: 26838788
[TBL] [Abstract][Full Text] [Related]
3. Resident cell lineages are preserved in pulmonary vascular remodeling.
Crnkovic S; Marsh LM; El Agha E; Voswinckel R; Ghanim B; Klepetko W; Stacher-Priehse E; Olschewski H; Bloch W; Bellusci S; Olschewski A; Kwapiszewska G
J Pathol; 2018 Apr; 244(4):485-498. PubMed ID: 29359814
[TBL] [Abstract][Full Text] [Related]
4. Smooth muscle cell-specific FoxM1 controls hypoxia-induced pulmonary hypertension.
Dai J; Zhou Q; Tang H; Chen T; Li J; Raychaudhuri P; Yuan JX; Zhou G
Cell Signal; 2018 Nov; 51():119-129. PubMed ID: 30092353
[TBL] [Abstract][Full Text] [Related]
5. Deletion of LR11 Attenuates Hypoxia-Induced Pulmonary Arterial Smooth Muscle Cell Proliferation With Medial Thickening in Mice.
Jiang L; Konishi H; Nurwidya F; Satoh K; Takahashi F; Ebinuma H; Fujimura K; Takasu K; Jiang M; Shimokawa H; Bujo H; Daida H
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1972-9. PubMed ID: 27493099
[TBL] [Abstract][Full Text] [Related]
6. NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial Hypertension.
Dumas SJ; Bru-Mercier G; Courboulin A; Quatredeniers M; Rücker-Martin C; Antigny F; Nakhleh MK; Ranchoux B; Gouadon E; Vinhas MC; Vocelle M; Raymond N; Dorfmüller P; Fadel E; Perros F; Humbert M; Cohen-Kaminsky S
Circulation; 2018 May; 137(22):2371-2389. PubMed ID: 29444988
[TBL] [Abstract][Full Text] [Related]
7. PAR-2 inhibition reverses experimental pulmonary hypertension.
Kwapiszewska G; Markart P; Dahal BK; Kojonazarov B; Marsh LM; Schermuly RT; Taube C; Meinhardt A; Ghofrani HA; Steinhoff M; Seeger W; Preissner KT; Olschewski A; Weissmann N; Wygrecka M
Circ Res; 2012 Apr; 110(9):1179-91. PubMed ID: 22461388
[TBL] [Abstract][Full Text] [Related]
8. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target.
Kikuchi N; Satoh K; Kurosawa R; Yaoita N; Elias-Al-Mamun M; Siddique MAH; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Saito Y; Hoshikawa Y; Okada Y; Shimokawa H
Circulation; 2018 Aug; 138(6):600-623. PubMed ID: 29636330
[TBL] [Abstract][Full Text] [Related]
9. GLI1+ Cells Contribute to Vascular Remodeling in Pulmonary Hypertension.
Chu X; Kheirollahi V; Lingampally A; Chelladurai P; Valasarajan C; Vazquez-Armendariz AI; Hadzic S; Khadim A; Pak O; Rivetti S; Wilhelm J; Bartkuhn M; Crnkovic S; Moiseenko A; Heiner M; Kraut S; Atefi LS; Koepke J; Valente G; Ruppert C; Braun T; Samakovlis C; Alexopoulos I; Looso M; Chao CM; Herold S; Seeger W; Kwapiszewska G; Huang X; Zhang JS; Pullamsetti SS; Weissmann N; Li X; El Agha E; Bellusci S
Circ Res; 2024 May; 134(11):e133-e149. PubMed ID: 38639105
[TBL] [Abstract][Full Text] [Related]
10. Smooth Muscle Insulin-Like Growth Factor-1 Mediates Hypoxia-Induced Pulmonary Hypertension in Neonatal Mice.
Sun M; Ramchandran R; Chen J; Yang Q; Raj JU
Am J Respir Cell Mol Biol; 2016 Dec; 55(6):779-791. PubMed ID: 27438786
[TBL] [Abstract][Full Text] [Related]
11. Basigin mediates pulmonary hypertension by promoting inflammation and vascular smooth muscle cell proliferation.
Satoh K; Satoh T; Kikuchi N; Omura J; Kurosawa R; Suzuki K; Sugimura K; Aoki T; Nochioka K; Tatebe S; Miyamichi-Yamamoto S; Miura M; Shimizu T; Ikeda S; Yaoita N; Fukumoto Y; Minami T; Miyata S; Nakamura K; Ito H; Kadomatsu K; Shimokawa H
Circ Res; 2014 Sep; 115(8):738-50. PubMed ID: 25149188
[TBL] [Abstract][Full Text] [Related]
12. FGF12 (Fibroblast Growth Factor 12) Inhibits Vascular Smooth Muscle Cell Remodeling in Pulmonary Arterial Hypertension.
Yeo Y; Yi ES; Kim JM; Jo EK; Seo S; Kim RI; Kim KL; Sung JH; Park SG; Suh W
Hypertension; 2020 Dec; 76(6):1778-1786. PubMed ID: 33100045
[TBL] [Abstract][Full Text] [Related]
13. Platelet-Derived TGF (Transforming Growth Factor)-β1 Enhances the Aerobic Glycolysis of Pulmonary Arterial Smooth Muscle Cells by PKM2 (Pyruvate Kinase Muscle Isoform 2) Upregulation.
Zhu Y; Shu D; Gong X; Lu M; Feng Q; Zeng XB; Zhang H; Gao J; Guo YW; Liu L; Ma R; Zhu L; Hu Q; Ming ZY
Hypertension; 2022 May; 79(5):932-945. PubMed ID: 35232222
[TBL] [Abstract][Full Text] [Related]
14. Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation.
Zhang L; Wang Y; Wu G; Rao L; Wei Y; Yue H; Yuan T; Yang P; Xiong F; Zhang S; Zhou Q; Chen Z; Li J; Mo BW; Zhang H; Xiong W; Wang CY
Cell Prolif; 2020 Feb; 53(2):e12742. PubMed ID: 31943454
[TBL] [Abstract][Full Text] [Related]
15. Suppression of HIF2 signalling attenuates the initiation of hypoxia-induced pulmonary hypertension.
Hu CJ; Poth JM; Zhang H; Flockton A; Laux A; Kumar S; McKeon B; Mouradian G; Li M; Riddle S; Pugliese SC; Brown RD; Wallace EM; Graham BB; Frid MG; Stenmark KR
Eur Respir J; 2019 Dec; 54(6):. PubMed ID: 31515405
[TBL] [Abstract][Full Text] [Related]
16. Critical role of VGLL4 in the regulation of chronic normobaric hypoxia-induced pulmonary hypertension in mice.
Tian Q; Fan X; Ma J; Li D; Han Y; Yin X; Wang H; Huang T; Wang Z; Shentu Y; Xue F; Du C; Wang Y; Mao S; Fan J; Gong Y
FASEB J; 2021 Aug; 35(8):e21822. PubMed ID: 34314061
[TBL] [Abstract][Full Text] [Related]
17. Mineralocorticoid receptor antagonism attenuates experimental pulmonary hypertension.
Preston IR; Sagliani KD; Warburton RR; Hill NS; Fanburg BL; Jaffe IZ
Am J Physiol Lung Cell Mol Physiol; 2013 May; 304(10):L678-88. PubMed ID: 23457185
[TBL] [Abstract][Full Text] [Related]
18. Lysyl oxidases play a causal role in vascular remodeling in clinical and experimental pulmonary arterial hypertension.
Nave AH; Mižíková I; Niess G; Steenbock H; Reichenberger F; Talavera ML; Veit F; Herold S; Mayer K; Vadász I; Weissmann N; Seeger W; Brinckmann J; Morty RE
Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1446-58. PubMed ID: 24833797
[TBL] [Abstract][Full Text] [Related]
19. Endothelial HIF signaling regulates pulmonary fibrosis-associated pulmonary hypertension.
Bryant AJ; Carrick RP; McConaha ME; Jones BR; Shay SD; Moore CS; Blackwell TR; Gladson S; Penner NL; Burman A; Tanjore H; Hemnes AR; Karwandyar AK; Polosukhin VV; Talati MA; Dong HJ; Gleaves LA; Carrier EJ; Gaskill C; Scott EW; Majka SM; Fessel JP; Haase VH; West JD; Blackwell TS; Lawson WE
Am J Physiol Lung Cell Mol Physiol; 2016 Feb; 310(3):L249-62. PubMed ID: 26637636
[TBL] [Abstract][Full Text] [Related]
20. SPARC, a Novel Regulator of Vascular Cell Function in Pulmonary Hypertension.
Veith C; Vartürk-Özcan I; Wujak M; Hadzic S; Wu CY; Knoepp F; Kraut S; Petrovic A; Gredic M; Pak O; Brosien M; Heimbrodt M; Wilhelm J; Weisel FC; Malkmus K; Schäfer K; Gall H; Tello K; Kosanovic D; Sydykov A; Sarybaev A; Günther A; Brandes RP; Seeger W; Grimminger F; Ghofrani HA; Schermuly RT; Kwapiszewska G; Sommer N; Weissmann N
Circulation; 2022 Mar; 145(12):916-933. PubMed ID: 35175782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
